Collagen type IV Human Protein
Specifications
| Product Data | |
| Species | Human |
|---|---|
| Protein Source | Placenta |
| Concentration | 1.0 mg/ml by nanodrop at 205 nm |
| Purity | This product has been prepared from human placenta and is chromatographically and immunologically pure. This product is free from other collagens, human serum proteins and non-collagen extracellular matrix proteins. This product reacts with anti-Collagen Type IV. Reaction with Rockland’s anti-Collagen I, II, III, V or VI is negligible. |
| Buffer | 0.5 M Acetic Acid |
| Preparation | Liquid (sterile filtered) purified protein |
| Recommended Dilution | ELISA,Immunohistochemistry,Western Blot |
| Protein Description | This antigen is free from other Collagens, Human serum proteins and non-Collagen extracellular matrix proteins and reacts with anti-Collagen Type IV. Reaction with anti-Collagen I, II, III, V or VI is negligible (typically less than 1% cross reactivity was detected by ELISA). |
| Note | Collagen type IV has been tested in SDS-Page and can be used as a control or standard in indirect trapping ELISA for quantitation of antigen using a standard curve, for immunoprecipitation and for other immunological assays as optimized by the user. Specific conditions should be optimized by user. |
| Storage | Store vial at 4° C prior to opening. This product is stable at 4° C as an undiluted liquid. Dilute only prior to immediate use. |
| Stability | Expiration date is six (6) months from date of receipt. |
| Shipping | Blue Ice |
| Reference Data | |
| RefSeq | NP_001290039 |
| Locus ID | 1282 |
| Cytogenetics | 13q34 |
| Synonyms | Type IV collagen, collagen 4, human collagen, Collagen alpha-4 (IV) chain |
| Summary | This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. provided by RefSeq, Dec 2014 |
| Protein Categories | Cardiovascular diseases, Growth Factors, Intracellular Proteins, Secreated Proteins |
| Protein Families | ELISA. Suitable for use as a Control or standard in indirect trapping ELISA for quantitation of antigen in serum using a standard curve. Immunoprecipitation. Western blotting. |
| Protein Pathways | ECM-receptor interaction, Focal adhesion, Pathways in cancer, Small cell lung cancer |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Citations
Rama, Mohapatra, Melcher et al
Adv Sci (Weinh) (2022) 9 (10), e2105783 DOI: 10.1002/advs.202105783
Sharma, Tupe, Wallner et al
Am. J. Physiol. Renal Physiol. (2017)
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.